| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |